Equity-High Impact Factor Journals

High Impact List of Articles

• Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy Soraru Gianni

  Editorial: Clinical Investigation

• Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy Soraru Gianni

  Editorial: Clinical Investigation

• Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy Soraru Gianni

  Editorial: Clinical Investigation

• Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy Soraru Gianni

  Editorial: Clinical Investigation

• Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy Soraru Gianni

  Editorial: Clinical Investigation

• Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy Soraru Gianni

  Editorial: Clinical Investigation

• Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial Thomas Kaulhausen

  Methodology: Clinical Investigation

• Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial Thomas Kaulhausen

  Methodology: Clinical Investigation

• Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial Thomas Kaulhausen

  Methodology: Clinical Investigation

• Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial Thomas Kaulhausen

  Methodology: Clinical Investigation

• Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial Thomas Kaulhausen

  Methodology: Clinical Investigation

• Efficacy of an interspinous decompression device versus nonoperative treatment for lumbar spinal stenosis: an example for a randomized, controlled trial Thomas Kaulhausen

  Methodology: Clinical Investigation

• Challenges of developing new drugs for childhood cancers Frank M Balis, Elizabeth Fox

  Clinical Trail Perspective: Clinical Investigation

• Challenges of developing new drugs for childhood cancers Frank M Balis, Elizabeth Fox

  Clinical Trail Perspective: Clinical Investigation

• Challenges of developing new drugs for childhood cancers Frank M Balis, Elizabeth Fox

  Clinical Trail Perspective: Clinical Investigation

• Challenges of developing new drugs for childhood cancers Frank M Balis, Elizabeth Fox

  Clinical Trail Perspective: Clinical Investigation

• Challenges of developing new drugs for childhood cancers Frank M Balis, Elizabeth Fox

  Clinical Trail Perspective: Clinical Investigation

• Challenges of developing new drugs for childhood cancers Frank M Balis, Elizabeth Fox

  Clinical Trail Perspective: Clinical Investigation

• Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials Ramit Ravona-Springer, Amos D Korczyn

  Review Article: Clinical Investigation

• Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials Ramit Ravona-Springer, Amos D Korczyn

  Review Article: Clinical Investigation

• Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials Ramit Ravona-Springer, Amos D Korczyn

  Review Article: Clinical Investigation

• Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials Ramit Ravona-Springer, Amos D Korczyn

  Review Article: Clinical Investigation

• Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials Ramit Ravona-Springer, Amos D Korczyn

  Review Article: Clinical Investigation

• Current conceptions of the etiology and risk factors for Alzheimer\\\'s disease and their possible implications on the design of dementia clinical trials Ramit Ravona-Springer, Amos D Korczyn

  Review Article: Clinical Investigation

• Drug-eluting balloons: where are we and what are the problems? Beatrix Schnorr, Ulrich Speck, Bruno Scheller

  Editorial: Clinical Investigation

• Drug-eluting balloons: where are we and what are the problems? Beatrix Schnorr, Ulrich Speck, Bruno Scheller

  Editorial: Clinical Investigation

• Drug-eluting balloons: where are we and what are the problems? Beatrix Schnorr, Ulrich Speck, Bruno Scheller

  Editorial: Clinical Investigation

• Drug-eluting balloons: where are we and what are the problems? Beatrix Schnorr, Ulrich Speck, Bruno Scheller

  Editorial: Clinical Investigation

• Drug-eluting balloons: where are we and what are the problems? Beatrix Schnorr, Ulrich Speck, Bruno Scheller

  Editorial: Clinical Investigation

• Drug-eluting balloons: where are we and what are the problems? Beatrix Schnorr, Ulrich Speck, Bruno Scheller

  Editorial: Clinical Investigation

Relevant Topics in Clinical